Answers are grounded in this paper and cite their sources.
While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer's disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope. Herein, we review the pathophysiology and clinical evidence for cardiovascular complications caused by acetylcholinesterase inhibitors in patients being treated for dementia and discuss options for their management.
No takes yet. Share an insight, caveat, or question.
Young et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: